These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 25518507)

  • 1. [Pulmonary hypertension in Russia: the first results of the national register].
    Chazova IE; Arkhipova OA; Valieva ZS; Nakonechnikov SN; Martyniuk TV
    Ter Arkh; 2014; 86(9):56-64. PubMed ID: 25518507
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Characteristics of patients with chronic thromboembolic pulmonary hypertension according to the Russian National Registry].
    Valieva ZS; Martynyuk TV; Nakonechnikov SN; Chazova IE
    Ter Arkh; 2021 Sep; 93(9):1058-1065. PubMed ID: 36286865
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bosentan for patients with chronic thromboembolic pulmonary hypertension.
    Vassallo FG; Kodric M; Scarduelli C; Harari S; Potena A; Scarda A; Piattella M; Cassandro R; Confalonieri M
    Eur J Intern Med; 2009 Jan; 20(1):24-9. PubMed ID: 19237088
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bosentan or Macitentan Therapy in Chronic Thromboembolic Pulmonary Hypertension?
    van Thor MCJ; Ten Klooster L; Snijder RJ; Kelder JC; Mager JJ; Post MC
    Lung; 2019 Dec; 197(6):753-760. PubMed ID: 31583452
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute improved hemodynamics following inhaled iloprost in chronic thromboembolic pulmonary hypertension.
    Krug S; Hammerschmidt S; Pankau H; Wirtz H; Seyfarth HJ
    Respiration; 2008; 76(2):154-9. PubMed ID: 17804899
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Features of clinical, functional and hemodynamics profile, medical treatment and prognosis evaluation in patients with inoperable chronic thromboembolic pulmonary hypertension and idiopathic pulmonary arterial hypertension according to the Russian registry].
    Chazova IE; Valieva ZS; Nakonechnikov SN; Taran IN; Martynyuk TV
    Ter Arkh; 2019 Sep; 91(9):77-87. PubMed ID: 32598818
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and Instrumental Characteristics of Newly Diagnosed Patients with Various Forms of Pulmonary Hypertension according to the Russian National Registry.
    Chazova IY; Martynyuk TV; Valieva ZS; Gratsianskaya SY; Aleevskaya AM; Zorin AV; Nakonechnikov SN
    Biomed Res Int; 2020; 2020():6836973. PubMed ID: 32626754
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of sarcoidosis-associated pulmonary hypertension: A single centre retrospective experience using targeted therapies.
    Keir GJ; Walsh SL; Gatzoulis MA; Marino PS; Dimopoulos K; Alonso R; Raposeiras-Roubin S; Renzoni EA; Maher TM; Wells AU; Wort SJ
    Sarcoidosis Vasc Diffuse Lung Dis; 2014 Jul; 31(2):82-90. PubMed ID: 25078636
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bosentan for treatment of inoperable chronic thromboembolic pulmonary hypertension: BENEFiT (Bosentan Effects in iNopErable Forms of chronIc Thromboembolic pulmonary hypertension), a randomized, placebo-controlled trial.
    Jaïs X; D'Armini AM; Jansa P; Torbicki A; Delcroix M; Ghofrani HA; Hoeper MM; Lang IM; Mayer E; Pepke-Zaba J; Perchenet L; Morganti A; Simonneau G; Rubin LJ;
    J Am Coll Cardiol; 2008 Dec; 52(25):2127-34. PubMed ID: 19095129
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The economic burden of chronic thromboembolic pulmonary hypertension in Russian Federation.
    Chazova IE; Martynyuk TV; Valieva ZS; Nakonechnikov SN; Nedogoda SV; Salasyuk AS; Taran IN; Gratsianskaya SE
    Ter Arkh; 2018 Sep; 90(9):101-109. PubMed ID: 30701743
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Medical and surgical management for chronic thromboembolic pulmonary hypertension: a single center experience.
    Coronel ML; Chamorro N; Blanco I; Amado V; Del Pozo R; Pomar JL; Badia JR; Rovira I; Matute P; Argemí G; Castellà M; Barberà JA
    Arch Bronconeumol; 2014 Dec; 50(12):521-7. PubMed ID: 24957814
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic thromboembolic pulmonary hypertension (CTEPH): results from an international prospective registry.
    Pepke-Zaba J; Delcroix M; Lang I; Mayer E; Jansa P; Ambroz D; Treacy C; D'Armini AM; Morsolini M; Snijder R; Bresser P; Torbicki A; Kristensen B; Lewczuk J; Simkova I; Barberà JA; de Perrot M; Hoeper MM; Gaine S; Speich R; Gomez-Sanchez MA; Kovacs G; Hamid AM; Jaïs X; Simonneau G
    Circulation; 2011 Nov; 124(18):1973-81. PubMed ID: 21969018
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic thromboembolic pulmonary hypertension.
    Hoeper MM; Madani MM; Nakanishi N; Meyer B; Cebotari S; Rubin LJ
    Lancet Respir Med; 2014 Jul; 2(7):573-82. PubMed ID: 24898750
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Multicenter study of disease attributes in adult patients with pulmonary hypertension].
    Dong L; He JG; Liu ZH; Lu XL; Zeng WJ; Sun YJ; Ni XH; Gu Q; Zhao ZH; Cheng XS; Xiong CM
    Zhonghua Yi Xue Za Zhi; 2012 Apr; 92(16):1087-90. PubMed ID: 22781764
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pulmonary arterial hypertension in Russia: six-year observation analysis of the National Registry.
    Chazova IE; Arkhipova OA; Martynyuk TV
    Ter Arkh; 2019 Mar; 91(1):24-31. PubMed ID: 31090367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Bosentan: a considerable increase in the survival of patients with pulmonary hypertension associated with systemic rheumatic diseases].
    Volkov AV; Iudkina NN; Nikolaeva EV; Kurmukov IA; Glukhova SI; Nasonov EL
    Ter Arkh; 2014; 86(5):32-9. PubMed ID: 25026800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiopulmonary exercise testing to evaluate the exercise capacity of patients with inoperable chronic thromboembolic pulmonary hypertension: an endothelin receptor antagonist improves the peak PETCO2.
    Hirashiki A; Adachi S; Nakano Y; Kono Y; Shimazu S; Shimizu S; Morimoto R; Okumura T; Takeshita K; Yamada S; Murohara T; Kondo T
    Life Sci; 2014 Nov; 118(2):397-403. PubMed ID: 24641953
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pulmonary Arterial Hypertension-Specific Drug Therapy in COPD Patients with Severe Pulmonary Hypertension and Mild-to-Moderate Airflow Limitation.
    Calcaianu G; Canuet M; Schuller A; Enache I; Chaouat A; Kessler R
    Respiration; 2016; 91(1):9-17. PubMed ID: 26492415
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Chronic thromboembolic pulmonary hypertension: Time delay from onset of symtoms to diagnosis and clinical condition at diagnosis].
    Held M; Grün M; Holl R; Walter F; Schäfers HJ; Graeter T; Wilkens H; Jany B
    Dtsch Med Wochenschr; 2014 Aug; 139(33):1647-52. PubMed ID: 25093951
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The oxygen kinetic effect of inhaled iloprost in pulmonary artery hypertension and chronic thromboembolic pulmonary hypertension].
    Cui N; Yang YH; Xie WM; Ma ZH; Luo L; Wang C
    Zhonghua Jie He He Hu Xi Za Zhi; 2009 Jul; 32(7):522-6. PubMed ID: 19954007
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.